Search Results
Apr 17, 2026, 16:15 ET UNITED BANCSHARES, INC. ANNOUNCES FIRST QUARTER 2026 RESULTS AND $0.25 DIVIDEND
DirectorsRobert L. BenrothHerbert H. Huffman IIIDaniel W. Schutt, ChairmanR. Steven Unverferth
More news about: United Bancshares, Inc.
Apr 17, 2026, 16:01 ET Kalohexis Announces Poster Presentation at the American Association for Cancer Research Annual Meeting 2026
TrialPresentation Number: CT219Date and Time: April 21, 2026, 9:00 a.m. – 12:00 p.m. PTSession: Phase II and Phase III Clinical Trials in ProgressLocation: Poster Section 51; Poster Board #14About KalohexisKalohexis is a clinical-stage
More news about: Kalohexis
Apr 17, 2026, 15:00 ET Nested Therapeutics Reports Initial Encouraging Clinical Activity and Favorable Tolerability of NST-628, a Brain-Penetrant Pan-RAF/MEK Molecular Glue, at AACR 2026
advanced/metastatic NRAS and BRAF Class II/III melanoma following failure of standard therapyResponses observed across multiple RAS/MAPK-driven tumors with early evidence of CNS activityApproximately 8,000 NRAS and BRAF Class II/III melanoma patients diagnosed
More news about: Nested Therapeutics Inc.
Apr 17, 2026, 15:00 ET Meiji Holdings Co., Ltd. Highlights that Yogurt Containing Bacteria Metabolite Shows a Tendency Toward Higher Response When Added to Immune Checkpoint Inhibitor Therapy in People Living with Non-small Cell Lung Cancer
meaningfully support the efficacy of modern lung cancer immunotherapy.Notably, all three treatment outcomes also exceeded those reported in the Phase III clinical trials of the study's standard therapies that supported their regulatory approval.Various types of EPSs produced by lactic acid bacteria
More news about: Meiji Holdings Co Ltd
Apr 17, 2026, 14:58 ET New ACP Breast Cancer Screening Guidelines Are a Step Backward that May Cost Lives
Screening for Women at Higher-Than-Average Risk: Updated Recommendations from the ACR. Journal of the American College of Radiology. 2023.iii Radhakrishnan A, Nowak S, Parker A et al. Physician Breast Cancer Screening Recommendations Following Guideline Changes. JAMA Intern Med. 2017.iv Arleo
More news about: American College of Radiology
Apr 17, 2026, 10:39 ET Bracco Receives Health Canada Approval for VUEWAY® injection (gadopiclenol), Advancing Lower-Dose MRI Contrast Imaging
information).The product has been also approved for use on paediatric population from birth by FDA in US and EMA in Europe.Details on Phase III clinical trials are available on
More news about: Bracco Group
Apr 17, 2026, 10:00 ET ScreenPoint Medical Secures $16M to Lead the Next Phase of AI in Breast Cancer Care
mammography and digital tomosynthesis for breast cancer screening: a paired, noninferiority trial." Nature Medicine. March 2026.[iii] Transpara is intended for use as a concurrent reading aid for physicians interpreting screening FFDM and DBT exams, to identify regions suspicious
More news about: ScreenPoint Medical
Apr 17, 2026, 08:56 ET LAKE UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Lakeland Industries (LAKE) Investors of Securities Class Action Deadline on April 24, 2026
these businesses on Lakeland's financial results, as well as the overall strength and quality of Pacific Helmets' and Jolly's respective operations; (iii) Lakeland's business and financial results were significantly deteriorating because of, inter alia, tariff-related headwinds and timing, certification
More news about: Faruqi & Faruqi, LLP
Apr 17, 2026, 08:51 ET MONDAY DEADLINE: Berger Montague Advises NuScale Power Corporation (NYSE: SMR) Investors to Inquire About a Securities Fraud Class Action by April 20, 2026
qualifications attributed to ENTRA1 actually referred to principals of the Habboush Group, a distinct entity without significant nuclear energy experience; and (iii) NuScale's commercialization strategy was exposed to undisclosed risks of failure, delays, regulatory challenges, and other setbacks.According
More news about: Berger Montague
Apr 17, 2026, 08:39 ET CWH UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Camping World Holdings (CWH) Investors of Securities Class Action Deadline on May 11, 2026
optimize profit using "data analytics;" (ii) the Company overstated the retail demand of consumers it was experiencing and/or reasonably expected; (iii) as a result, the Company would require "strict, corrective inventory management objectives," negatively impacting gross profit and margins; (iv) the
More news about: Faruqi & Faruqi, LLP
Apr 17, 2026, 08:17 ET PINS UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Pinterest (PINS) Investors of Securities Class Action Deadline on May 29, 2026
reallocating resources to AI-focused roles and teams that drive AI adoption and execution, (ii) prioritizing AI powered products and capabilities, and (iii) accelerating the transformation of its sales and go-to-market approach."On this news, Pinterest's stock price fell $2.49 per share, or 9.61%,
More news about: Faruqi & Faruqi, LLP
Apr 17, 2026, 07:56 ET Einride Appoints U.S. General Keith B. Alexander to the Board of Directors, Further Scaling its Defense Business
[email protected] Merger Corp. IIIEric RosenfeldChief SPAC OfficerLegato Merger Corp. III[email protected] This
More news about: Einride
Apr 17, 2026, 07:49 ET Einride Appoints U.S. General Keith B. Alexander to the Board of Directors, Further Scaling its Defense Business
[email protected] Merger Corp. IIIEric RosenfeldChief SPAC OfficerLegato Merger Corp. III[email protected] This
More news about: Einride
Apr 17, 2026, 07:25 ET MONDAY INVESTOR DEADLINE: NuScale Power Corporation (SMR) Investors with Substantial Losses Have Opportunity to Lead Class Action - RGRD Law
of NuScale capital to an entity that lacked any significant prior experience owning, financing, or operating nuclear energy generation facilities; (iii) the purported experience and qualifications attributed to ENTRA1 by defendants during the Class Period in fact referred to the purported experience
More news about: Robbins Geller Rudman & Dowd LLP
Apr 17, 2026, 06:30 ET Hyperscale Data Announces Strategic Partnership with AGIBOT for AI Robotics
initiatives."We believe this Agreement represents an important step in expanding Hyperscale Data's capabilities in AI and robotics," stated Milton "Todd" Ault III, Executive Chairman of Hyperscale Data. "We look forward to discussing this initiative in more detail during our previously announced webcast on April
More news about: Hyperscale Data Inc.
Apr 17, 2026, 02:06 ET Delska 在里加正式啟用波羅的海地區其中一座最先進、最可持續發展的數據中心
此項目也體現科技拓展與可持續發展如何相輔相成。」此項目解決了歐洲主要數據中心樞紐的容量不足問題，促使企業轉向尋找仍有容量的地區。 同時，這亦標誌著波羅的海地區開始強化自身，成為北歐一個既富競爭力又可持續發展的數碼基礎設施樞紐。關於數據中心該 7,100 平方米的模組化設施可擴展至 30 MW。 每個機架最高可支援 250 kW，並且達到 Tier III 標準，確保 99.982% 的正常運行時間。設施以 PUE 低於 1.3 為目標，電力來自北歐的風能、太陽能及水力等可再生能源，後備發電機則使用 Neste MY 可再生柴油。關於 DelskaDelska 是波羅的海地區頂尖的數據中心營運商，擁有逾
More news about: Delska
Apr 17, 2026, 01:30 ET WuXi Biologics Recognized by Morningstar Sustainalytics as Industry and Regional ESG Leader for Sixth Year
operations, and more efficient manufacturing. As of December 31, 2025, WuXi Biologics is supporting 945 integrated client projects, including 74 in Phase III and 25 in commercial manufacturing, with complex modalities representing more than half of the entire project portfolio.WuXi Biologics regards
More news about: WuXi Biologics
Apr 16, 2026, 23:39 ET Delska inaugura en Riga uno de los centros de datos más avanzados y sostenibles de los países bálticos
datosEsta instalación modular de 7.100 m² permite una expansión de hasta 30 MW. Admite hasta 250 kW por rack y cumple con el estándar Tier III, lo que garantiza una disponibilidad del 99,982 %.Con el objetivo de alcanzar una eficacia del uso de energía (PUE, por sus siglas en inglés)
More news about: Delska
Apr 16, 2026, 23:29 ET Delska lança um dos data centers mais avançados e sustentáveis dos países bálticos em Riga
Europa.Sobre o Data CenterA instalação modular de 7.100 m² permite expansão para até 30 MW. Ela suporta até 250 kW por rack e atende ao padrão Tier III, garantindo 99,982% de tempo de atividade.Com meta de PUE <1,3, a unidade é alimentada por energia renovável de fontes eólicas, solares e hidrelétricas
More news about: Delska
Apr 16, 2026, 19:00 ET ORVANA REPORTS Q2 FY2026 PRODUCTION RESULTS AND PROVIDES UPDATE ON OXIDES STOCKPILE PROJECT AT DON MARIO, BOLIVIA
commissioning and ramp-up activities; (ii) no material disruptions to operations due to labour, supply chain, power, equipment damage or other events; (iii) permitting, development, operations and expansion activities at Orovalle, Don Mario and Taguas proceeding consistent with the Company's current expectations;
More news about: Orvana Minerals Corp.
Apr 16, 2026, 18:17 ET GEMI Stockholders Have Rights - If You Lost Money Investing in Gemini Space Station, Inc. Contact Robbins LLP for Information About Recovering Your Losses
platform; (ii) Gemini had overstated its commitment to and/or the viability of growing its business through expanding its international operations; (iii) accordingly, Gemini's post-IPO financial and business prospects were overstated; (iv) all of the foregoing raised a non-speculative risk that Gemini
More news about: Robbins LLP
Apr 16, 2026, 18:10 ET ATRA Stockholders Have Rights - If You Lost Money Investing in Atara Biotherapeutics, Inc. Contact Robbins LLP for Information About Recovering Your Losses
ALLELE study, made it unlikely that the FDA would approve the tabelecleucel BLA; (ii) accordingly, tabelecleucel's regulatory prospects were overstated; (iii) the aforementioned manufacturing issues also subjected Atara to a heightened risk of regulatory scrutiny, as well as jeopardized its ongoing clinical
More news about: Robbins LLP
Apr 16, 2026, 18:07 ET BW Stockholder Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Against Babcock & Wilcox Enterprises, Inc.
(ii) Applied Digital did not need the products and services that B&W would purportedly supply pursuant to the Power Generation LNTP and Contract; (iii) the foregoing, at the very least, would raise questions about the parties' actual intent behind entering into the Power Generation LNTP and Contract,
More news about: Robbins LLP
Apr 16, 2026, 14:25 ET How IBM Quantum is Enabling Healthcare and Biology Research
twelve research teams from around the world receiving access to a combined $40 million in funding. By March 2026, that group had narrowed to six Phase III finalists. Now, the winners have been announced.Wellcome
More news about: IBM
Apr 16, 2026, 12:15 ET INVESTOR DEADLINE: monday.com Ltd. (MNDY) Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
expansion within existing accounts and longer enterprise sales cycles, making monday.com's $1.8 billion 2027 target increasingly unlikely to be met; and (iii) defendants misled investors by providing the public with materially flawed statements of confidence and growth projections which did not account for
More news about: Robbins Geller Rudman & Dowd LLP